组织工程用水凝胶材料

综述了目前用于组织工程支架材料的水凝胶,包括胶原和明胶、透明质酸盐、海藻酸盐,琼脂糖和壳聚糖等天然水凝胶,聚丙烯酸及其衍生物、聚氧化乙烯及其衍生共聚物、聚乙烯醇、聚磷腈和合成多肽等合成水凝胶,并介绍了可注射性组织工程水凝胶。     

壳聚糖基智能水凝胶的研究进展

壳聚糖是一种天然高分子,含有氨基和羟基等特征基团;水凝胶是一种高分子交联网络体系,具有亲水性,在水中能够溶胀并保持大量水分而不溶解;“智能化”是自发地对外界环境刺激产生响应的一种特性.壳聚糖基智能水凝胶具有良好的生物相容性和可降解性,正倍受广大研究学者的关注.文章综述了近年来关于pH敏感型、温度敏感型以及pH/温度双重敏感型壳聚糖基智能水凝胶的研究概况,介绍了壳聚糖基水凝胶在医学领域如组织工程、药物释放方面的应用并对其未来的发展方向进行了探讨.     

PNIPAM温敏微凝胶在生物医学领域中的应用研究

水凝胶因其良好的生物相容性及环境刺激响应性而在生物医学领域有着广泛的用途,但仍存在机械强度差、响应速度慢、不能生物降解等缺点。针对这些问题,特别是宏观水凝胶响应慢的问题,我们近年来以具有温度敏感性的聚N-异丙基丙烯酰胺(PNIPAM)微凝胶为基础,设计制备了一系列生物材料,分别应用于药物控释、生物传感以及组织工程等生物医学领域。我们设计制备了具有良好葡萄糖敏感性的PNIPAM微凝胶,实现了可自我调控的胰岛素可控释放。以PNIPAM微凝胶为基础,提出了新的聚合胶态晶体阵列光学传感方法,设计制备了多种可快速响应的新型生物光学传感器。实现了PNIPAM微凝胶的实时凝胶化,并将其发展成为一种新型的可注射细胞支架材料。进一步利用该体系的可逆性,提出了制备在药物筛选、肿瘤研究以及组织工程等领域有重要用途的多细胞球的新方法。     

海藻酸钠水凝胶的制备及其在药物释放中的应用

近年来,由于智能水凝胶在药物的控制释放、基因传送、组织工程等领域的应用前景诱人,研究者对智能水凝胶的研究十分活跃。合成类水凝胶常用的单体有丙烯酸及其衍生物、丙烯酰胺及其衍生物等,合成水凝胶具有较好的稳定性,但其生物降解性和生物相容性较差。天然类水凝胶的原料主要有壳聚糖、海藻酸钠、纤维素、淀粉等。由于这些天然多糖具有较好的生物相容性和生物降解性,同时价廉易得,因此,天然类水凝胶在药物控制释放领域更具有优势。海藻酸钠是β-D-甘露糖醛酸(β-D-mannuronic,M)和α-L-古洛糖醛酸(α-L-guluronic,G)按照(1→4)糖苷键连接而成的线型聚合物,每个糖醛酸单元上含有一个羧基,因此,海藻酸钠在中性或碱性条件下呈现聚阴离子电解质的性质。本文综述了海藻酸钠水凝胶的制备方法,包括物理交联法、化学交联法、酶交联法、互穿聚合物网络等;概述了海藻酸钠水凝胶在药物释放中的应用,包括口服给药、皮下给药、黏膜给药、肺部给药、经皮给药等;最后讨论了海藻酸钠水凝胶在研究与应用中存在的问题。     

糖超分子水凝胶在组织工程领域的研究进展

组织工程的一般策略是使用生物支架作为人工基质替代天然细胞外基质(ECM)支持细胞的生存和各项功能,从而形成新的组织.作为一类重要的生物大分子,糖质(glycan)是ECM的主要组分,其所承载的基质和信息功能使其成为一种极有潜力的制备组织工程支架的原材料.与此同时,基于可逆非共价相互作用的水凝胶,因其可以实现对水凝胶时空结构的精确操纵,从而模拟细胞所需的生存环境,促进组织的再生修复,近年来得到了重视和研究.本文从模拟ECM的结构和功能切入,将糖质功能与非共价作用结合起来,介绍多种糖动态超分子水凝胶的设计思路和构筑原理,讨论其在组织工程应用中需要实现的关键性能,并对其在该领域的发展趋势进行展望.     

水凝胶及其在药物控释体系上的应用

智能水凝胶作为药物载体有着良好的应用前景。人体环境中存在一些变化的因素，如温度、pH。因此，温度敏感性水凝胶和pH敏感性水凝胶可用于药物在人体中的控释体系。本文主要介绍水凝胶材料的种类以及智能水凝胶在药物控释体系上的应用。     

海藻酸盐凝胶化及其在软骨组织工程和药物控释领域的应用

介绍了海藻酸盐水溶液的凝胶化及其临界行为和松弛临界指数n.提出了将凝胶化按高分子的分子链长短分为生长型和交联型两类,前者为无规交联,符合逾渗连接的条件;后者大分子链间交联,不符合无规逾渗连接的条件.介绍了微囊化细胞载体、预成型支架和可注射支架,能够为软骨细胞提供良好的三维生长环境;通过LbL、二价离子交联等自组装技术,海藻酸能够实现对多种类型药物的包埋和控释.     

纳米复合水凝胶在人工软骨中的研究进展

纳米复合水凝胶(nanocomposite hydrogels,NC hydrogels)作为人工软骨修复材料有很大的应用价值和吸引力.由于NC水凝胶具有与天然软骨细胞外基质(extracellular matrix,ECM)相似的结构,以及较好的力学性能、刺激响应性等优势,是软骨修复的理想支架材料.本综述详细介绍了用...     

海藻酸盐凝胶化及其在软骨组织工程和药物控释领域的应用（专题报道）

 介绍了海藻酸盐水溶液的凝胶化及其临界行为和松弛临界指数n.提出了将凝胶化按高分子的分子链长短分为生长型和交联型两类,前者为无规交联,符合逾渗连接的条件;后者大分子链间交联,不符合无规逾渗连接的条件.介绍了微囊化细胞载体、预成型支架和可注射支架,能够为软骨细胞提供良好的三维生长环境;通过LbL、二价离子交联等自组装技术,海藻酸能够实现对多种类型药物的包埋和控释.     

可注射水凝胶的制备与应用

可注射水凝胶在再生医学和药物控释等方面有着广泛的用途,是近年来生物医用材料领域新的研究方向.本文综述了近年来人们在可注射水凝胶制备和应用方面的研究进展,最后展望了其发展前景.     

水凝胶的制备及应用

本文回顾了“普通”和“环境敏感”水凝胶的制备方法及其作为生物材料在固定化酶、固定化细胞、免疫测试和药物控制释放等领域的应用。     

微尺度水凝胶与组织工程

水凝胶已被广泛应用于组织工程、药物控释、生物传感器等生物医学领域。随着微制造技术的发展,在纳微米尺度范围内制备形状和尺寸与自然组织相匹配的工程化水凝胶为解决血管化困难、复杂组织结构模拟、多细胞接种等组织工程难题带来了曙光。本文将主要讨论微尺度水凝胶在组织工程领域的研究现状,重点介绍微尺度水凝胶的合成方法及其在血管化和复杂组织结构模拟方面的应用。     

Recent Strategies in Fabrication of Gradient Hydrogels for Tissue Engineering Applications

Hydrogels are widely used as scaffold in tissue engineering field because of their ability to mimic the cellular microenvironment. However, mimicking a completely natural cellular environment is complicated due to the differences in various physical and chemical properties of cellular environments. Recently, gradient hydrogels provide excellent heterogeneous environment to mimic the different cellular microenvironments. To create hydrogels with an anisotropic distribution, gradient hydrogels have been widely developed by adopting several gradient generation techniques. Herein, the various gradient hydrogel fabrication techniques, including dual syringe pump systems, microfluidic device, photolithography, diffusion, and bio‐printing are summarized. As the effects of gradient 3D hydrogels with stems have been reviewed elsewhere, this review focuses principally on gradient hydrogel fabrication for multi‐model tissue regeneration. This review provides new insights into the key points for fabrication of gradient hydrogels for multi‐model tissue regeneration.     

Human Albumin-Based Hydrogels for Their Potential Xeno-Free Microneedle Applications

Nowadays, hydrogels-based microneedles (MNs) have attracted a great interest owing to their outstanding qualities for biomedical applications. For the fabrication of hydrogels-based microneedles as tissue engineering scaffolds and drug delivery carriers, various biomaterials have been tested. They are required to feature tunable physiochemical properties, biodegradability, biocompatibility, nonimmunogenicity, high drug loading capacity, and sustained drug release. Among biomaterials, human proteins are the most ideal biomaterials for fabrication of hydrogels-based MNs; however, they are mechanically weak and poorly processible. To the best of the knowledge, there are no reports of xeno-free human protein-based MNs so far. Here, human albumin-based hydrogels and microneedles for tissue engineering and drug delivery by using relatively new processible human serum albumin methacryloyl (HSAMA) are engineered. The resultant HSAMA hydrogels display tunable mechanical properties, biodegradability, and good biocompatibility. Moreover, the xeno-free HSAMA microneedles display a sustained drug release profile and significant mechanical strength to penetrate the model skin. In vitro, they also show good biocompatibility and anticancer efficacy. Sustainable processible human albumin-based biomaterials may be employed as a xeno-free platform in vivo for tissue engineering and drug delivery in clinical trials in the future.     

Dendrimer-based Hydrogels with Controlled Drug Delivery Property for Tissue Adhesion

In recent years,the hydrogel-based tissue adhesives have been extensively investigated for their excellent biocompatibility and the ability to be administered directly within the adherent tissue.To meet the requirement for more controllable release in various physiological settings,the components of hydrogel adhesive should be more precisely tailored.In this work,the POSS-ace-PEG hydrogel adhesive was fabricated with the polyacetal dendrimer G1'-[NH3Cl]16 and poly(ethylene glycol) succinimidyl carbonate (PEG-SC) due to the regular peripheral amino structure of G1'-[NH3Cl]16.Rheological and adhesion tests demonstrated that the hydrogel adhesive had good mechanical and adhesive properties,which could effectively adhere to the pigskin and severed nerves.Moreover,the tissue adhesive exhibited good stability under neutral conditions and the rapid degradation under acidic conditions,allowing for the release of doxycycline hydrochloride (DOX) drug in response to pH.Together,these results suggested that the POSS-ace-PEG adhesive had the potential to provide an alternative to tissue adhesives for applications in pathological environments (inflammation,tumors,etc.).     

组织工程用可降解生物材料的研究进展

综述了组织工程的背景及组织工程用可降解生物材料的研究进展，重点介绍了当前的研究热点，并对组织工程用生物材料的发展方向进行了探讨。     

Self‐Healing Supramolecular Hydrogels for Tissue Engineering Applications

Self‐healing supramolecular hydrogels have emerged as a novel class of biomaterials that combine hydrogels with supramolecular chemistry to develop highly functional biomaterials with advantages including native tissue mimicry, biocompatibility, and injectability. These properties are endowed by the reversibly cross‐linked polymer network of the hydrogel. These hydrogels have great potential for realizing yet to be clinically translated tissue engineering therapies. This review presents methods of self‐healing supramolecular hydrogel formation and their uses in tissue engineering as well as future perspectives.     

基于动态建构化学的自愈合水凝胶及其在生物医学领域的应用展望

自愈合水凝胶与传统水凝胶相比,经受力破坏后仍可恢复其结构和功能,具有自我修复损伤的特点,是近年来备受关注的一种智能软材料.动态建构化学概念的引入,极大地促进了多响应性动态自愈合水凝胶的发展.本文综述了近年来基于动态建构化学合成自愈合水凝胶的方法,包括多重氢键作用、疏水相互作用、亚胺键、酰腙键等,并分析探讨了影响凝胶自愈合性能的因素及其在生物医学领域的潜在应用,还对其未来的发展进行了展望.     

Injectable Hydrogels for Cardiac Tissue Engineering

In light of the limited efficacy of current treatments for cardiac regeneration, tissue engineering approaches have been explored for their potential to provide mechanical support to injured cardiac tissues, deliver cardio‐protective molecules, and improve cell‐based therapeutic techniques. Injectable hydrogels are a particularly appealing system as they hold promise as a minimally invasive therapeutic approach. Moreover, injectable acellular alginate‐based hydrogels have been tested clinically in patients with myocardial infarction (MI) and show preservation of the left ventricular (LV) indices and left ventricular ejection fraction (LVEF). This review provides an overview of recent developments that have occurred in the design and engineering of various injectable hydrogel systems for cardiac tissue engineering efforts, including a comparison of natural versus synthetic systems with emphasis on the ideal characteristics for biomimetic cardiac materials.